BIOGEN INC. Income Tax Expense
BIOGEN INC. (BIIB) reported Income Tax Expense of $58.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-04-29
- BIOGEN INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $58.20M, a 17.68% decline year-over-year.
- BIOGEN INC. income tax expense (benefit) for the quarter ending 2025-12-31 was -$7.10M, a 128.63% decline year-over-year.
- BIOGEN INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $90.80M, a 45.28% increase year-over-year.
- BIOGEN INC. income tax expense (benefit) for the quarter ending 2025-06-30 was $109.20M, a 5.13% decline year-over-year.
- BIOGEN INC. income tax expense (benefit) for fiscal 2025 was $263.60M, a 3.73% decline from fiscal 2024.
- BIOGEN INC. income tax expense (benefit) for fiscal 2024 was $273.80M, a 102.37% increase from fiscal 2023.
- BIOGEN INC. income tax expense (benefit) for fiscal 2023 was $135.30M, a 78.62% decline from fiscal 2022.
- BIOGEN INC. income tax expense (benefit) for fiscal 2022 was $632.80M, a 1105.33% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $58.20M 10-Q · filed 2026-04-29 | $51.10M derived: sum of 2 quarters · filed 2026-04-29 | $141.90M derived: sum of 3 quarters · filed 2026-04-29 | $251.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $83.70M derived: sum of 2 quarters · filed 2026-02-06 | $192.90M derived: sum of 3 quarters · filed 2026-02-06 | $263.60M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $90.80M 10-Q · filed 2025-10-30 | $200.00M derived: sum of 2 quarters · filed 2025-10-30 | $270.70M 10-Q · filed 2025-10-30 | $295.50M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $109.20M 10-Q · filed 2025-07-31 | $179.90M 10-Q · filed 2025-07-31 | $204.70M derived: sum of 3 quarters · filed 2026-04-29 | $267.20M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $70.70M 10-Q · filed 2026-04-29 | $95.50M derived: sum of 2 quarters · filed 2026-04-29 | $158.00M derived: sum of 3 quarters · filed 2026-04-29 | $273.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $24.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $87.30M derived: sum of 2 quarters · filed 2026-02-06 | $202.40M derived: sum of 3 quarters · filed 2026-02-06 | $273.80M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $62.50M 10-Q · filed 2025-10-30 | $177.60M derived: sum of 2 quarters · filed 2025-10-30 | $249.00M 10-Q · filed 2025-10-30 | $291.70M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $115.10M 10-Q · filed 2025-07-31 | $186.50M 10-Q · filed 2025-07-31 | $229.20M derived: sum of 3 quarters · filed 2026-02-06 | $156.30M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $71.40M 10-Q · filed 2025-05-01 | $114.10M derived: sum of 2 quarters · filed 2026-02-06 | $41.20M derived: sum of 3 quarters · filed 2026-02-06 | $156.00M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $42.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$30.20M derived: sum of 2 quarters · filed 2026-02-06 | $84.60M derived: sum of 3 quarters · filed 2026-02-06 | $135.30M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | -$72.90M 10-Q · filed 2024-10-30 | $41.90M derived: sum of 2 quarters · filed 2024-10-30 | $92.60M 10-Q · filed 2024-10-30 | $146.90M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $114.80M 10-Q · filed 2024-08-01 | $165.50M 10-Q · filed 2024-08-01 | $219.80M derived: sum of 3 quarters · filed 2025-02-12 | $456.00M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $50.70M 10-Q · filed 2024-04-24 | $105.00M derived: sum of 2 quarters · filed 2025-02-12 | $341.20M derived: sum of 3 quarters · filed 2025-02-12 | $557.90M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $54.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $290.50M derived: sum of 2 quarters · filed 2025-02-12 | $507.20M derived: sum of 3 quarters · filed 2025-02-12 | $632.80M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $236.20M 10-Q · filed 2023-11-08 | $452.90M derived: sum of 2 quarters · filed 2023-11-08 | $578.50M 10-Q · filed 2023-11-08 | $1.02B derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $216.70M 10-Q · filed 2023-07-25 | $342.30M 10-Q · filed 2023-07-25 | $785.50M derived: sum of 3 quarters · filed 2024-02-14 | $759.60M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | $125.60M 10-Q · filed 2023-04-25 | $568.80M derived: sum of 2 quarters · filed 2024-02-14 | $542.90M derived: sum of 3 quarters · filed 2024-02-14 | $133.80M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $443.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $417.30M derived: sum of 2 quarters · filed 2024-02-14 | $8.20M derived: sum of 3 quarters · filed 2024-02-14 | $52.50M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$25.90M 10-Q · filed 2022-10-25 | -$435.00M derived: sum of 2 quarters · filed 2022-10-25 | -$390.70M 10-Q · filed 2022-10-25 | -$377.50M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | -$409.10M 10-Q · filed 2022-07-20 | -$364.90M 10-Q · filed 2022-07-20 | -$351.60M derived: sum of 3 quarters · filed 2023-02-15 | -$110.80M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $44.20M 10-Q · filed 2022-05-03 | $57.50M derived: sum of 2 quarters · filed 2023-02-15 | $298.30M derived: sum of 3 quarters · filed 2023-02-15 | $744.40M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | $13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $254.10M derived: sum of 2 quarters · filed 2023-02-15 | $700.20M derived: sum of 3 quarters · filed 2023-02-15 | $992.30M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $240.80M 10-Q · filed 2021-10-20 | $686.90M derived: sum of 2 quarters · filed 2021-10-20 | $979.00M 10-Q · filed 2021-10-20 | $1.25B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $446.10M 10-Q · filed 2021-07-22 | $738.20M 10-Q · filed 2021-07-22 | $1.01B derived: sum of 3 quarters · filed 2022-02-03 | $1.23B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $292.00M 10-Q · filed 2021-04-22 | $568.10M derived: sum of 2 quarters · filed 2022-02-03 | $779.40M derived: sum of 3 quarters · filed 2022-02-03 | $1.03B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $276.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $487.40M derived: sum of 2 quarters · filed 2022-02-03 | $735.50M derived: sum of 3 quarters · filed 2022-02-03 | $1.16B 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $211.30M 10-Q · filed 2020-10-21 | $459.40M derived: sum of 2 quarters · filed 2020-10-21 | $881.90M 10-Q · filed 2020-10-21 | $1.35B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $248.10M 10-Q · filed 2020-07-22 | $670.60M 10-Q · filed 2020-07-22 | $1.14B derived: sum of 3 quarters · filed 2021-02-03 | $1.51B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $422.50M 10-Q · filed 2020-04-23 | $892.10M derived: sum of 2 quarters · filed 2021-02-03 | $1.26B derived: sum of 3 quarters · filed 2021-02-03 | $1.53B derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $469.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $839.40M derived: sum of 2 quarters · filed 2021-02-03 | $1.10B derived: sum of 3 quarters · filed 2021-02-03 | $1.43B 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $369.80M 10-Q · filed 2019-10-22 | $633.50M derived: sum of 2 quarters · filed 2019-10-22 | $956.00M 10-Q · filed 2019-10-22 | $2.52B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $263.70M 10-Q · filed 2019-07-24 | $586.20M 10-Q · filed 2019-07-24 | $2.15B derived: sum of 3 quarters · filed 2020-02-06 | $2.54B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $322.50M 10-Q · filed 2019-04-24 | $1.89B derived: sum of 2 quarters · filed 2020-02-06 | $2.27B derived: sum of 3 quarters · filed 2020-02-06 | $2.54B derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $1.57B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $1.95B derived: sum of 2 quarters · filed 2020-02-06 | $2.22B derived: sum of 3 quarters · filed 2020-02-06 | $2.46B 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $383.80M 10-Q · filed 2018-10-23 | $653.40M derived: sum of 2 quarters · filed 2018-10-23 | $892.60M 10-Q · filed 2018-10-23 | $1.08B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $269.60M 10-Q · filed 2018-07-24 | $508.80M 10-Q · filed 2018-07-24 | $699.10M derived: sum of 3 quarters · filed 2019-02-06 | $1.04B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $239.20M 10-Q · filed 2018-04-24 | $429.50M derived: sum of 2 quarters · filed 2019-02-06 | $766.50M derived: sum of 3 quarters · filed 2019-02-06 | $1.12B derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $190.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $527.30M derived: sum of 2 quarters · filed 2019-02-06 | $880.90M derived: sum of 3 quarters · filed 2019-02-06 | $1.24B 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | $337.00M 10-Q · filed 2017-10-24 | $690.60M derived: sum of 2 quarters · filed 2017-10-24 | $1.05B 10-Q · filed 2017-10-24 | $1.30B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $353.60M 10-Q · filed 2017-07-25 | $710.00M 10-Q · filed 2017-07-25 | $967.10M derived: sum of 3 quarters · filed 2018-02-01 | $1.30B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $356.40M 10-Q · filed 2017-04-25 | $613.50M derived: sum of 2 quarters · filed 2018-02-01 | $943.60M derived: sum of 3 quarters · filed 2018-02-01 | $1.24B derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $257.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $587.20M derived: sum of 2 quarters · filed 2018-02-01 | $879.70M derived: sum of 3 quarters · filed 2018-02-01 | $1.16B 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $330.10M 10-Q · filed 2016-10-26 | $330.09M 10-Q · filed 2015-10-21 | $622.60M derived: sum of 2 quarters · filed 2016-10-26 | $904.50M 10-Q · filed 2016-10-26 | $904.48M 10-Q · filed 2015-10-21 | $1.17B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | $292.50M 10-Q · filed 2016-07-21 | $292.50M 10-Q · filed 2015-07-24 | $574.40M 10-Q · filed 2016-07-21 | $574.38M 10-Q · filed 2015-07-24 | $842.59M derived: sum of 3 quarters · filed 2017-02-02 | $1.12B derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | $281.90M 10-Q · filed 2016-04-21 | $281.88M 10-Q · filed 2015-04-24 | $550.09M derived: sum of 2 quarters · filed 2017-02-02 | $824.87M derived: sum of 3 quarters · filed 2017-02-02 | $1.09B derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $268.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $542.97M derived: sum of 2 quarters · filed 2017-02-02 | $811.49M derived: sum of 3 quarters · filed 2017-02-02 | $989.90M 10-K · filed 2017-02-02 | $989.94M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $274.77M 10-Q · filed 2015-10-21 | $543.29M derived: sum of 2 quarters · filed 2015-10-21 | $721.71M 10-Q · filed 2015-10-21 | $911.96M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $268.52M 10-Q · filed 2015-07-24 | $446.94M 10-Q · filed 2015-07-24 | $637.18M derived: sum of 3 quarters · filed 2016-02-03 | $823.29M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $178.41M 10-Q · filed 2015-04-24 | $368.66M derived: sum of 2 quarters · filed 2016-02-03 | $554.77M derived: sum of 3 quarters · filed 2016-02-03 | $713.91M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $190.25M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $376.35M derived: sum of 2 quarters · filed 2016-02-03 | $535.49M derived: sum of 3 quarters · filed 2016-02-03 | $601.00M 10-K · filed 2016-02-03 | $601.01M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $186.10M 10-Q · filed 2014-10-22 | $345.25M derived: sum of 2 quarters · filed 2014-10-22 | $410.75M 10-Q · filed 2014-10-22 | $547.09M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $159.14M 10-Q · filed 2014-07-23 | $224.65M 10-Q · filed 2014-07-23 | $360.99M derived: sum of 3 quarters · filed 2015-02-04 | $492.03M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $65.51M 10-Q · filed 2014-04-23 | $201.85M derived: sum of 2 quarters · filed 2015-02-04 | $332.89M derived: sum of 3 quarters · filed 2015-02-04 | $453.91M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $136.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $267.38M derived: sum of 2 quarters · filed 2015-02-04 | $388.41M derived: sum of 3 quarters · filed 2015-02-04 | $470.55M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $131.04M 10-Q · filed 2013-10-28 | $252.06M derived: sum of 2 quarters · filed 2013-10-28 | $334.21M 10-Q · filed 2013-10-28 | $439.13M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $121.02M 10-Q · filed 2013-07-25 | $203.17M 10-Q · filed 2013-07-25 | $308.09M derived: sum of 3 quarters · filed 2014-02-06 | $435.19M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $82.15M 10-Q · filed 2013-04-25 | $187.07M derived: sum of 2 quarters · filed 2014-02-06 | $314.17M derived: sum of 3 quarters · filed 2014-02-06 | $409.21M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $104.92M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $232.02M derived: sum of 2 quarters · filed 2014-02-06 | $327.06M derived: sum of 3 quarters · filed 2014-02-06 | $444.53M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $127.10M 10-Q · filed 2012-10-25 | $222.14M derived: sum of 2 quarters · filed 2012-10-25 | $339.61M 10-Q · filed 2012-10-25 | $418.38M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $95.04M 10-Q · filed 2012-07-24 | $212.50M 10-Q · filed 2012-07-24 | $291.27M derived: sum of 3 quarters · filed 2013-02-05 | $366.28M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $117.47M 10-Q · filed 2012-05-01 | $196.24M derived: sum of 2 quarters · filed 2013-02-05 | $271.25M derived: sum of 3 quarters · filed 2013-02-05 | $373.49M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $78.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $153.78M derived: sum of 2 quarters · filed 2013-02-05 | $256.02M derived: sum of 3 quarters · filed 2013-02-05 | $331.33M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $75.01M 10-Q · filed 2011-10-28 | $177.25M derived: sum of 2 quarters · filed 2011-10-28 | $252.56M 10-Q · filed 2011-10-28 | $336.31M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $102.24M 10-Q · filed 2011-07-26 | $177.55M 10-Q · filed 2011-07-26 | $261.30M derived: sum of 3 quarters · filed 2012-02-03 | $375.24M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $75.31M 10-Q · filed 2011-04-21 | $159.06M derived: sum of 2 quarters · filed 2012-02-03 | $272.99M derived: sum of 3 quarters · filed 2012-02-03 | $365.70M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | $83.75M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $197.68M derived: sum of 2 quarters · filed 2012-02-03 | $290.39M derived: sum of 3 quarters · filed 2012-02-03 | $355.62M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $113.94M 10-Q · filed 2010-10-26 | $206.65M derived: sum of 2 quarters · filed 2010-10-26 | $271.87M 10-Q · filed 2010-10-26 | $355.33M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | $92.71M 10-Q · filed 2010-07-20 | $157.93M 10-Q · filed 2010-07-20 | $241.39M derived: sum of 3 quarters · filed 2011-02-04 | $355.73M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | $65.22M 10-Q · filed 2010-04-20 | $148.68M derived: sum of 2 quarters · filed 2011-02-04 | $263.02M derived: sum of 3 quarters · filed 2011-02-04 | $347.72M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2008-12-31 | $83.46M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $197.79M derived: sum of 2 quarters · filed 2011-02-04 | $282.50M derived: sum of 3 quarters · filed 2011-02-04 | $365.78M 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | $114.34M 10-Q · filed 2009-10-21 | $199.04M derived: sum of 2 quarters · filed 2009-10-21 | $282.32M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $84.71M 10-Q · filed 2009-07-17 | $167.98M 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | $272.42M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |